PT  - JOURNAL ARTICLE
AU  - Song, Taejong
AU  - Choi, Chel Hun
AU  - Park, Hwang Shin
AU  - Kim, Min-Kyu
AU  - Lee, Yoo-Young
AU  - Kim, Tae-Joong
AU  - Lee, Jeong-Won
AU  - Bae, Duk-Soo
AU  - Kim, Byoung-Gie
TI  - Fertility-Sparing Surgery for Borderline Ovarian Tumors: Oncologic Safety and Reproductive Outcomes
AID  - 10.1097/IGC.0b013e3182129842
DP  - 2011 Apr 01
TA  - International Journal of Gynecologic Cancer
PG  - 640--646
VI  - 21
IP  - 4
4099  - http://ijgc.bmj.com/content/21/4/640.short
4100  - http://ijgc.bmj.com/content/21/4/640.full
SO  - Int J Gynecol Cancer2011 Apr 01; 21
AB  - Introduction: To evaluate the oncological safety and reproductive outcomes of patients with borderline ovarian tumors (BOTs) treated with fertility-sparing surgery.Methods: Patients with BOTs who underwent radical or fertility-sparing surgery between 1997 and 2009 were identified from an institutional database. The recurrence rates were compared between the 2 surgery groups. To compare the reproductive outcomes, all patients who underwent fertility-sparing surgery were interviewed by telephone.Results: One hundred forty-three patients underwent radical surgery, and 155 patients underwent fertility-sparing surgery. After a median interval of 38 months from the initial surgery (range, 10-77 months), 19 patients had a recurrence. The recurrence rate was similar in the radical and fertility-sparing surgery groups (4.9% and 7.7%, respectively; P = 0.280). In the fertility-sparing surgery group, however, the main site of recurrence was the remaining ovary that was successfully salvaged with a second round of fertility-sparing surgery. Of 51 patients who attempted to conceive, 45 patients (88.2%) were successful and resulted in 54 term deliveries.Conclusions: Fertility-sparing surgery for BOTs is safe and can result in future pregnancies, suggesting that such surgery should be considered for young patients who desire preservation of fertility.